PharmaResearch Co (XKRX:214450) Ending Cash Position : ₩0 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co Ending Cash Position?

PharmaResearch Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩0 Mil.

PharmaResearch Co's quarterly Ending Cash Position declined from Sep. 2023 (₩80,252 Mil) to Dec. 2023 (₩67,245 Mil) and declined from Dec. 2023 (₩67,245 Mil) to Mar. 2024 (₩0 Mil).

PharmaResearch Co's annual Ending Cash Position increased from Dec. 2021 (₩41,674 Mil) to Dec. 2022 (₩72,931 Mil) but then declined from Dec. 2022 (₩72,931 Mil) to Dec. 2023 (₩67,245 Mil).

PharmaResearch Co Ending Cash Position Historical Data

The historical data trend for PharmaResearch Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaResearch Co Ending Cash Position Chart

PharmaResearch Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

19,737.96

26,715.01

41,674.47

72,931.46

67,244.84

PharmaResearch Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															80,267.17	68,099.96	80,252.49	67,244.84	-

PharmaResearch Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PharmaResearch Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	72931.464	+	-5686.623
	=	67,245

PharmaResearch Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

PharmaResearch Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaResearch Co (XKRX:214450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400

Website

http://www.pr-products.co.kr

PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines